GeoVax Labs, Inc.
GOVX
$3.15
$0.279.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 183.44% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 183.44% | -- | -- | -- |
| Cost of Revenue | -31.87% | 10.57% | 20.99% | 22.04% | 6.55% |
| Gross Profit | -9.32% | 2.50% | 16.00% | -8.18% | 33.60% |
| SG&A Expenses | 7.13% | 42.01% | 15.78% | 9.64% | -24.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.27% | 16.94% | 19.70% | 19.69% | 0.52% |
| Operating Income | -8.86% | -7.05% | 8.12% | -8.46% | 31.92% |
| Income Before Tax | -8.66% | -6.04% | 8.42% | -8.83% | 30.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.66% | -6.04% | 8.42% | -8.83% | 30.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.66% | -6.04% | 8.42% | -8.83% | 30.84% |
| EBIT | -8.86% | -7.05% | 8.12% | -8.46% | 31.92% |
| EBITDA | -9.14% | -7.22% | 8.11% | -8.49% | 32.14% |
| EPS Basic | 65.69% | 82.47% | 81.87% | 77.65% | 80.89% |
| Normalized Basic EPS | 65.69% | 82.47% | 81.87% | 77.65% | 80.89% |
| EPS Diluted | 65.69% | 82.47% | 81.87% | 77.65% | 80.89% |
| Normalized Diluted EPS | 65.69% | 82.47% | 81.87% | 77.65% | 80.89% |
| Average Basic Shares Outstanding | 216.75% | 504.72% | 404.96% | 386.96% | 261.93% |
| Average Diluted Shares Outstanding | 216.75% | 504.72% | 404.96% | 386.96% | 261.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |